Absci (ABSI) Common Equity (2020 - 2026)

Absci (ABSI) reported Common Equity of $172.0 million for Q1 2026, down 13.49% on a YoY basis from $198.8 million in Q1 2025, and down 9.23% sequentially from $189.4 million in Q4 2025.

Absci (ABSI) Common Equity (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Common Equity data on file, last reported at $172.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Common Equity fell 13.49% year-over-year to $172.0 million; the trailing twelve-month figure through Mar 2026 stood at $172.0 million (down 13.49% YoY), and the FY2025 full-year result was $189.4 million, up 5.76% from the prior year.
  • Common Equity slipped to $172.0 million in Q1 2026, from $189.4 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $340.5 million in Q1 2022 to a low of $172.0 million in Q1 2026.
  • A 5-year average of $226.6 million and a median of $210.3 million in 2025 frame the typical range for Common Equity.
  • Across the five-year window, Common Equity surged 445.67% in 2022 and tumbled 35.8% in 2023, its largest moves.
  • Tracing ABSI's Common Equity over 5 years: stood at $274.4 million in 2022, then plunged by 35.8% to $176.2 million in 2023, then gained by 1.68% to $179.1 million in 2024, then advanced by 5.76% to $189.4 million in 2025, then decreased by 9.23% to $172.0 million in 2026.
  • Business Quant data shows ABSI's Common Equity at $172.0 million in Q1 2026, $189.4 million in Q4 2025, and $210.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Absci 1.23 Bn 1.11 Bn - 171.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 171.97 Mn
Dec 31, 2025 189.45 Mn
Sep 30, 2025 210.34 Mn
Jun 30, 2025 173.37 Mn
Mar 31, 2025 198.80 Mn
Dec 31, 2024 179.13 Mn
Sep 30, 2024 201.34 Mn
Jun 30, 2024 221.49 Mn
Mar 31, 2024 240.11 Mn
Dec 31, 2023 176.18 Mn
Sep 30, 2023 196.42 Mn
Jun 30, 2023 215.40 Mn
Mar 31, 2023 253.97 Mn
Dec 31, 2022 274.41 Mn
Sep 30, 2022 292.94 Mn
Jun 30, 2022 316.19 Mn
Mar 31, 2022 340.50 Mn
Dec 31, 2021 366.11 Mn
Sep 30, 2021 388.01 Mn
Jun 30, 2021 -124.26 Mn